Ricardo Correa, MD, EdD, the director of the University of Arizona endocrinology fellowship, told MedPage Today in 2022 that compounders are probably using the same active pharmacological part [semaglutide], but when you combine things and you add different excipients, the effectiveness if you dont measure that in a randomized controlled trial will not be the same. He added that not knowing exactly what the formulation contains makes prescribing too risky for him and the patient: Youre treating 100 patients and all of them have been doing fine with a compound medication you recommend
In this Ground Truths post Ill review them by 2 categories: (1) the peptides that have been FDA approved but are getting extensive off-label use
KOI Peptides: Readers Following MiraviGLPs Top-ranked Pick Why it stands out: KOI Peptides, run as Koi Research Labs, ranks highly in MiraviGLPs content rankings
Therefore, the data on how GLP-1s impact nutrient levels is in its infancy
MR generates MRPs that include several protein/peptide-saccharide conjugates